{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T23:39:54Z","timestamp":1794440394957,"version":"4.9.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NIH","award":["U01-AI035042"],"award-info":[{"award-number":["U01-AI035042"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01-HL146201"],"award-info":[{"award-number":["U01-HL146201"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    A man living with HIV was found to lack expression of CD16A on his natural killer (NK) cells and monocytes. Genetic analysis revealed compound heterozygous deletion of\n                    <jats:italic>FCGR3A<\/jats:italic>\n                    , the gene encoding CD16A. The case\u2019s NK cells showed: (a) no antibody-dependent cell-mediated cytotoxicity and very low spontaneous cytotoxicity; (b) an immature phenotype marked by high expression of CD94, CD2, NKG2A, and NKG2D, and low expression of KIR2DL2 and CD57; (c) no expression of KIR3DL1 and very low expression of FcR\u03b3; and (d) normal cytokine production. The case\u2019s monocytes and DCs were similar phenotypically and functionally to those from the donors matched for HIV status, age, and percentage of NK cells in the peripheral blood. In contrast to previously reported people with CD16A deficiency, this man did not have a history of severe infections with herpes viruses, suggesting that other immune cells and\/or immunoregulatory function of NK cells may compensate for deficiency of cytolytic NK cells.\n                  <\/jats:p>","DOI":"10.1007\/s10875-025-01886-y","type":"journal-article","created":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T04:34:48Z","timestamp":1748061288000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Complete CD16A Deficiency and Defective NK Cell Function in a Man Living with HIV"],"prefix":"10.1007","volume":"45","author":[{"given":"Weiying","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan F.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Mohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxann","family":"Ingersoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter E.","family":"Shoucair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay H.","family":"Bream","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tricia L.","family":"Nilles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robbie B.","family":"Mailliard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph B.","family":"Margolick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,24]]},"reference":[{"key":"1886_CR1","doi-asserted-by":"publisher","first-page":"5640","DOI":"10.1182\/blood-2012-01-380121","volume":"119","author":"P Bruhns","year":"2012","unstructured":"Bruhns P. Properties of mouse and human IgG receptors and their contribution to disease models. Blood. 2012;119:5640\u20139.","journal-title":"Blood"},{"key":"1886_CR2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nri2206","volume":"8","author":"F Nimmerjahn","year":"2008","unstructured":"Nimmerjahn F, Ravetch JV. Fc\u03b3 receptors as regulators of immune responses. Nat Rev Immunol. 2008;8:34\u201347.","journal-title":"Nat Rev Immunol"},{"key":"1886_CR3","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nri3582","volume":"14","author":"M Guilliams","year":"2014","unstructured":"Guilliams M, Bruhns P, Saeys Y, Hammad H, Lambrecht BN. The function of Fc\u03b3 receptors in dendritic cells and macrophages. Nat Rev Immunol. 2014;14:94\u2013108.","journal-title":"Nat Rev Immunol"},{"key":"1886_CR4","doi-asserted-by":"publisher","first-page":"34310","DOI":"10.1038\/srep34310","volume":"6","author":"WH Yeap","year":"2016","unstructured":"Yeap WH, Wong KL, Shimasaki N, Teo ECY, Quek JKS, Yong HX, et al. CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes. Sci Rep. 2016;6:34310.","journal-title":"Sci Rep"},{"key":"1886_CR5","doi-asserted-by":"publisher","first-page":"3769","DOI":"10.1172\/JCI64837","volume":"122","author":"JT Grier","year":"2012","unstructured":"Grier JT, Forbes LR, Monaco-Shawver L, Oshinsky J, Atkinson TP, Moody C, et al. Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity. J Clin Invest. 2012;122:3769\u201380.","journal-title":"J Clin Invest"},{"key":"1886_CR6","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.1083\/jcb.201712085","volume":"217","author":"K Srpan","year":"2018","unstructured":"Srpan K, Ambrose A, Karampatzakis A, Saeed M, Cartwright ANR, Guldevall K, et al. Shedding of CD16 disassembles the NK cell immune synapse and boosts serial engagement of target cells. J Cell Biol. 2018;217:3267\u201383.","journal-title":"J Cell Biol"},{"key":"1886_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1182\/blood-2005-04-1351","volume":"107","author":"YT Bryceson","year":"2006","unstructured":"Bryceson YT, March ME, Ljunggren H-G, Long EO. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood. 2006;107:159\u201366.","journal-title":"Blood"},{"key":"1886_CR8","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.4049\/jimmunol.0801665","volume":"182","author":"N Meknache","year":"2009","unstructured":"Meknache N, J\u00f6nsson F, Laurent J, Guinnepain M-T, Da\u00ebron M. Human basophils express the Glycosylphosphatidylinositol-Anchored Low-Affinity IgG receptor Fc\u03b3RIIIB (CD16B). J Immunol. 2009;182:2542\u201350.","journal-title":"J Immunol"},{"key":"1886_CR9","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1182\/blood-2018-07-864538","volume":"133","author":"J Golay","year":"2019","unstructured":"Golay J, Valgardsdottir R, Musaraj G, Giupponi D, Spinelli O, Introna M. Human neutrophils express low levels of Fc\u03b3RIIIA, which plays a role in PMN activation. Blood. 2019;133:1395\u2013405.","journal-title":"Blood"},{"key":"1886_CR10","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/humu.23159","volume":"38","author":"R Rahbari","year":"2017","unstructured":"Rahbari R, Zuccherato LW, Tischler G, Chihota B, Ozturk H, Saleem S, et al. Understanding the genomic structure of Copy-Number variation of the Low\u2010Affinity Fc\u03b3 receptor region allows confirmation of the association of FCGR3B deletion with rheumatoid arthritis. Hum Mutat. 2017;38:390\u20139.","journal-title":"Hum Mutat"},{"key":"1886_CR11","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.ajhg.2012.04.018","volume":"90","author":"LR Machado","year":"2012","unstructured":"Machado LR, Hardwick RJ, Bowdrey J, Bogle H, Knowles TJ, Sironi M, et al. Evolutionary history of Copy-Number-Variable locus for the Low-Affinity Fc\u03b3 receptor: mutation rate, autoimmune disease, and the legacy of helminth infection. Am J Hum Genet. 2012;90:973\u201385.","journal-title":"Am J Hum Genet"},{"key":"1886_CR12","doi-asserted-by":"publisher","first-page":"E640","DOI":"10.1002\/humu.20997","volume":"30","author":"WB Breunis","year":"2009","unstructured":"Breunis WB, van Mirre E, Geissler J, Laddach N, Wolbink G, Schoot E, van der, et al. Copy number variation at the FCGR locus includes FCGR3A, FCGR2C and FCGR3B but not FCGR2A and FCGR2B. Hum Mutat. 2009;30:E640\u201350.","journal-title":"Hum Mutat"},{"key":"1886_CR13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/imr.12341","volume":"268","author":"CE Hargreaves","year":"2015","unstructured":"Hargreaves CE, Rose-Zerilli MJJ, Machado LR, Iriyama C, Hollox EJ, Cragg MS, et al. Fc\u03b3 receptors: genetic variation, function, and disease. Immunol Rev. 2015;268:6\u201324.","journal-title":"Immunol Rev"},{"key":"1886_CR14","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00439-016-1669-3","volume":"135","author":"J Wu","year":"2016","unstructured":"Wu J, Li Y, Guan W, Viken K, Perlman DM, Bhargava M. FCGR3A and FCGR3B copy number variations are risk factors for sarcoidosis. Hum Genet. 2016;135:715\u201325.","journal-title":"Hum Genet"},{"key":"1886_CR15","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1177\/0961203317700485","volume":"26","author":"Y Qi","year":"2017","unstructured":"Qi Y, Zhou X, Bu D, Hou P, Lv J, Zhang H. Low copy numbers of FCGR3A and FCGR3B associated with Chinese patients with SLE and AASV. Lupus. 2017;26:1383\u20139.","journal-title":"Lupus"},{"key":"1886_CR16","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1002\/art.38813","volume":"66","author":"J-Y Chen","year":"2014","unstructured":"Chen J-Y, Wang C-M, Chang S-W, Cheng C-H, Wu Y-JJ, Lin J-C, et al. Association of FCGR3A and FCGR3B copy number variations with systemic lupus erythematosus and rheumatoid arthritis in Taiwanese patients. Arthritis Rheumatol. 2014;66:3113\u201321.","journal-title":"Arthritis Rheumatol"},{"key":"1886_CR17","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1182\/blood-2014-01-553024","volume":"124","author":"T Azzi","year":"2014","unstructured":"Azzi T, L\u00fcnemann A, Murer A, Ueda S, B\u00e9ziat V, Malmberg K-J, et al. Role for early-differentiated natural killer cells in infectious mononucleosis. Blood. 2014;124:2533\u201343.","journal-title":"Blood"},{"key":"1886_CR18","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.jaci.2019.11.049","volume":"145","author":"A P\u00e9rez-Portilla","year":"2020","unstructured":"P\u00e9rez-Portilla A, Moraru M, Bl\u00e1zquez-Moreno A, Kolb P, Garc\u00eda-Morato MB, Ranganath T, et al. Identification of the first cases of complete CD16A deficiency: association with persistent EBV infection. J Allergy Clin Immunol. 2020;145:1288\u201392.","journal-title":"J Allergy Clin Immunol"},{"key":"1886_CR19","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.puhe.2011.11.013","volume":"126","author":"R Detels","year":"2012","unstructured":"Detels R, Jacobson L, Margolick J, Martinez-Maza O, Munoz A, Phair J, et al. The multicenter AIDS Cohort Study. 1983 to.\u2026 Public Health. 2012;126:196\u20138.","journal-title":"\u2026 Public Health"},{"key":"1886_CR20","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1086\/522762","volume":"45","author":"M Lazo","year":"2007","unstructured":"Lazo M, Gange SJ, Wilson TE, Anastos K, Ostrow DG, Witt MD, et al. Patterns and predictors of changes in adherence to highly active antiretroviral therapy: longitudinal study of men and women. Clin Infect Dis. 2007;45:1377\u201385.","journal-title":"Clin Infect Dis"},{"key":"1886_CR21","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1093\/gerona\/glv132","volume":"70","author":"W Zhang","year":"2015","unstructured":"Zhang W, Nilles TL, Johnson JR, Margolick JB, Regulatory T. Cells, Frailty, and immune activation in men who have sex with men in the Multicenter AIDS Cohort Study. J Gerontol Biol Sci Med Sci. 2015;70:1533\u201341.","journal-title":"J Gerontol Biol Sci Med Sci"},{"key":"1886_CR22","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/cyto.a.20859","volume":"77A","author":"P Autissier","year":"2010","unstructured":"Autissier P, Soulas C, Burdo TH, Williams KC. Evaluation of a 12-color flow cytometry panel to study lymphocyte, monocyte, and dendritic cell subsets in humans. Cytometry A. 2010;77A:410\u20139.","journal-title":"Cytometry A"},{"key":"1886_CR23","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1182\/blood.V88.8.3022.bloodjournal8883022","volume":"88","author":"E de Vries","year":"1996","unstructured":"de Vries E, Koene HR, Vossen JM, Gratama JW, von dem Borne AE, Waaijer JL, et al. Identification of an unusual Fc gamma receptor IIIa (CD16) on natural killer cells in a patient with recurrent infections. Blood. 1996;88:3022\u20137.","journal-title":"Blood"},{"key":"1886_CR24","doi-asserted-by":"crossref","unstructured":"Roederer M. Compensation in flow cytometry. In: J. Paul Robinson, editor. Curr Protoc Cytom; 2002. Wiley.","DOI":"10.1002\/0471142956.cy0114s22"},{"key":"1886_CR25","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1101\/gr.214874.116","volume":"27","author":"NI Weisenfeld","year":"2017","unstructured":"Weisenfeld NI, Kumar V, Shah P, Church DM, Jaffe DB. Direct determination of diploid genome sequences. Genome Res. 2017;27:757\u201367.","journal-title":"Genome Res"},{"key":"1886_CR26","doi-asserted-by":"crossref","unstructured":"Weisenfeld NI, Kumar V, Shah P, Church DM, Jaffe DB, Corrigendum. Direct determination of diploid genome sequences. Genome Res. 2018;28:606.1\u2013606.1.","DOI":"10.1101\/gr.235812.118"},{"key":"1886_CR27","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/cyto.a.22625","volume":"87","author":"S Van Gassen","year":"2015","unstructured":"Van Gassen S, Callebaut B, Van Helden MJ, Lambrecht BN, Demeester P, Dhaene T, et al. FlowSOM: using self-organizing maps for visualization and interpretation of cytometry data. Cytom Part J Int Soc Anal Cytol. 2015;87:636\u201345.","journal-title":"Cytom Part J Int Soc Anal Cytol"},{"key":"1886_CR28","doi-asserted-by":"publisher","first-page":"e1007308","DOI":"10.1371\/journal.pgen.1007308","volume":"14","author":"Y Choi","year":"2018","unstructured":"Choi Y, Chan AP, Kirkness E, Telenti A, Schork NJ. Comparison of phasing strategies for whole human genomes. PLOS Genet. 2018;14:e1007308.","journal-title":"PLOS Genet"},{"key":"1886_CR29","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41590-020-0593-9","volume":"21","author":"Y Wang","year":"2020","unstructured":"Wang Y, Lifshitz L, Gellatly K, Vinton CL, Busman-Sahay K, McCauley S, et al. HIV-1-induced cytokines deplete homeostatic innate lymphoid cells and expand TCF7 -dependent memory NK cells. Nat Immunol. 2020;21:274\u201386.","journal-title":"Nat Immunol"},{"key":"1886_CR30","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.immuni.2017.10.008","volume":"47","author":"AG Freud","year":"2017","unstructured":"Freud AG, Mundy-Bosse BL, Yu J, Caligiuri MA. The broad spectrum of human natural killer cell diversity. Immunity. 2017;47:820\u201333.","journal-title":"Immunity"},{"key":"1886_CR31","doi-asserted-by":"crossref","unstructured":"McInnes L, Healy J, Melville JUMAP. Uniform Manifold Approximation and Projection for Dimension Reduction [Internet]. arXiv; 2020 [cited 2023 Sep 1]. Available from: http:\/\/arxiv.org\/abs\/1802.03426","DOI":"10.1038\/s43586-024-00363-x"},{"key":"1886_CR32","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jim.2007.05.013","volume":"325","author":"GG Kim","year":"2007","unstructured":"Kim GG, Donnenberg VS, Donnenberg AD, Gooding W, Whiteside TL. A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: comparisons to a 4\u00a0h 51Cr-release assay. J Immunol Methods. 2007;325:51\u201366.","journal-title":"J Immunol Methods"},{"key":"1886_CR33","doi-asserted-by":"publisher","unstructured":"Bryceson YT, Fauriat C, Nunes JM, Wood SM, Bj\u00f6rkstr\u00f6m NK, Long EO et al. Functional Analysis of Human NK Cells by Flow Cytometry. In: Campbell KS, editor. Nat Kill Cell Protoc Cell Mol Methods [Internet]. Totowa, NJ: Humana Press, 2010;335\u201352. Available from: https:\/\/doi.org\/10.1007\/978-1-60761-362-6_23","DOI":"10.1007\/978-1-60761-362-6_23"},{"key":"1886_CR34","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jim.2005.09.018","volume":"308","author":"VR G\u00f3mez-Rom\u00e1n","year":"2006","unstructured":"G\u00f3mez-Rom\u00e1n VR, Florese RH, Patterson LJ, Peng B, Venzon D, Aldrich K, et al. A simplified method for the rapid fluorometric assessment of antibody-dependent cell-mediated cytotoxicity. J Immunol Methods. 2006;308:53\u201367.","journal-title":"J Immunol Methods"},{"key":"1886_CR35","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.4049\/jimmunol.2000430","volume":"205","author":"RR Anderko","year":"2020","unstructured":"Anderko RR, Rinaldo CR, Mailliard RB. IL-18 responsiveness defines limitations in immune help for specialized FcR\u03b3\u2013 NK cells. J Immunol. 2020;205:3429\u201342.","journal-title":"J Immunol"},{"key":"1886_CR36","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1084\/jem.20050128","volume":"202","author":"RB Mailliard","year":"2005","unstructured":"Mailliard RB, Alber SM, Shen H, Watkins SC, Kirkwood JM, Herberman RB, et al. IL-18\u2013induced CD83\u2009+\u2009CCR7\u2009+\u2009NK helper cells. J Exp Med. 2005;202:941\u201353.","journal-title":"J Exp Med"},{"key":"1886_CR37","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/cyto.a.24545","volume":"101","author":"KE Hally","year":"2022","unstructured":"Hally KE, Ferrer-Font L, Pilkington KR, Larsen PD. OMIP 083: A 21-marker 18-color flow cytometry panel for in-depth phenotyping of human peripheral monocytes. Cytometry A. 2022;101:374\u20139.","journal-title":"Cytometry A"},{"key":"1886_CR38","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ebiom.2019.03.077","volume":"43","author":"J Kristoff","year":"2019","unstructured":"Kristoff J, Palma ML, Garcia-Bates TM, Shen C, Sluis-Cremer N, Gupta P, et al. Type 1-programmed dendritic cells drive antigen-specific latency reversal and immune elimination of persistent HIV-1. EBioMedicine. 2019;43:295\u2013306.","journal-title":"EBioMedicine"},{"key":"1886_CR39","doi-asserted-by":"crossref","unstructured":"Mailliard RB, Smith KN, Fecek RJ, Rappocciolo G, Nascimento EJM, Marques ET, et al. Selective induction of CTL \u2018helper\u2019 rather than killer activity by natural epitope variants promotes DC-mediated HIV-1 dissemination. J Immunol. 2013;191:2570\u201380.","DOI":"10.4049\/jimmunol.1300373"},{"key":"1886_CR40","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1097\/QAD.0000000000001602","volume":"31","author":"A Agudelo-Hernandez","year":"2017","unstructured":"Agudelo-Hernandez A, Chen Y, Bullotta A, Buchanan WG, Klamar-Blain CR, Borowski L, et al. Subclinical herpesvirus shedding among HIV-1-infected men on antiretroviral therapy. AIDS. 2017;31:2085\u201394.","journal-title":"AIDS"},{"key":"1886_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S1386-6532(02)00197-X","volume":"25","author":"HGM Niesters","year":"2002","unstructured":"Niesters HGM. Clinical virology in real time. J Clin Virol. 2002;25:3\u201312.","journal-title":"J Clin Virol"},{"key":"1886_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jviromet.2011.05.012","volume":"176","author":"M Ding","year":"2011","unstructured":"Ding M, Bullotta A, Caruso L, Gupta P, Rinaldo CR, Chen Y. An optimized sensitive method for quantitation of DNA\/RNA viruses in heparinized and cryopreserved plasma. J Virol Methods. 2011;176:1\u20138.","journal-title":"J Virol Methods"},{"key":"1886_CR43","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nmeth.4149","volume":"14","author":"KE Diggins","year":"2017","unstructured":"Diggins KE, Greenplate AR, Leelatian N, Wogsland CE, Irish JM. Characterizing cell subsets using marker enrichment modeling. Nat Methods. 2017;14:275\u20138.","journal-title":"Nat Methods"},{"key":"1886_CR44","doi-asserted-by":"crossref","unstructured":"Nagelkerke SQ, Schmidt DE, de Haas M, Kuijpers TW. Genetic Variation in Low-To-Medium-Affinity Fc\u03b3 Receptors: Functional Consequences, Disease Associations, and Opportunities for Personalized Medicine. Front Immunol [Internet]. 2019;(10). https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6786274\/","DOI":"10.3389\/fimmu.2019.02237"},{"key":"1886_CR45","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/ni1582","volume":"9","author":"E Vivier","year":"2008","unstructured":"Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol. 2008;9:503.","journal-title":"Nat Immunol"},{"key":"1886_CR46","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1182\/blood-2008-09-179754","volume":"113","author":"P Bruhns","year":"2009","unstructured":"Bruhns P, Iannascoli B, England P, Mancardi DA, Fernandez N, Jorieux S, et al. Specificity and affinity of human Fc\u03b3 receptors and their polymorphic variants for human IgG subclasses. Blood. 2009;113:3716\u201325.","journal-title":"Blood"},{"key":"1886_CR47","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1182\/blood-2009-04-215491","volume":"115","author":"J Yu","year":"2010","unstructured":"Yu J, Mao HC, Wei M, Hughes T, Zhang J, Park I, et al. CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets. Blood. 2010;115:274\u201381.","journal-title":"Blood"},{"key":"1886_CR48","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.immuni.2006.06.013","volume":"25","author":"N Anfossi","year":"2006","unstructured":"Anfossi N, Andr\u00e9 P, Guia S, Falk CS, Roetynck S, Stewart CA, et al. Human NK cell education by inhibitory receptors for MHC class I. Immunity. 2006;25:331\u201342.","journal-title":"Immunity"},{"key":"1886_CR49","doi-asserted-by":"publisher","first-page":"E5645","DOI":"10.1073\/pnas.1706483114","volume":"114","author":"A Bl\u00e1zquez-Moreno","year":"2017","unstructured":"Bl\u00e1zquez-Moreno A, Park S, Im W, Call MJ, Call ME, Reyburn HT. Transmembrane features governing Fc receptor CD16A assembly with CD16A signaling adaptor molecules. Proc Natl Acad Sci. 2017;114:E5645\u201354.","journal-title":"Proc Natl Acad Sci"},{"key":"1886_CR50","doi-asserted-by":"publisher","first-page":"101709","DOI":"10.1016\/j.isci.2020.101709","volume":"23","author":"W Liu","year":"2020","unstructured":"Liu W, Scott JM, Langguth E, Chang H, Park PH, Kim S. FcR\u03b3 gene editing reprograms conventional NK cells to display key features of adaptive human NK cells. iScience. 2020;23:101709.","journal-title":"iScience"},{"key":"1886_CR51","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/nri3044","volume":"11","author":"JC Sun","year":"2011","unstructured":"Sun JC, Lanier LL. NK cell development, homeostasis and function: parallels with CD8\u2009+\u2009T cells. Nat Rev Immunol. 2011;11:645\u201357.","journal-title":"Nat Rev Immunol"},{"key":"1886_CR52","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1182\/blood.2019000925","volume":"135","author":"MT Lam","year":"2020","unstructured":"Lam MT, Mace EM, Orange JS. A research-driven approach to the identification of novel natural killer cell deficiencies affecting cytotoxic function. Blood. 2020;135:629\u201337.","journal-title":"Blood"},{"key":"1886_CR53","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.jaci.2013.07.020","volume":"132","author":"JS Orange","year":"2013","unstructured":"Orange JS. Natural killer cell deficiency. J Allergy Clin Immunol. 2013;132:515\u201326.","journal-title":"J Allergy Clin Immunol"},{"key":"1886_CR54","doi-asserted-by":"publisher","first-page":"5272","DOI":"10.1172\/JCI134966","volume":"130","author":"EM Mace","year":"2020","unstructured":"Mace EM, Paust S, Conte MI, Baxley RM, Schmit MM, Patil SL, et al. Human NK cell deficiency as a result of biallelic mutations in MCM10. J Clin Invest. 2020;130:5272\u201386.","journal-title":"J Clin Invest"},{"key":"1886_CR55","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/jleuko\/qiac007","volume":"113","author":"RR Anderko","year":"2023","unstructured":"Anderko RR, Mailliard RB. Mapping the interplay between NK cells and HIV: therapeutic implications. J Leukoc Biol. 2023;113:109\u201338.","journal-title":"J Leukoc Biol"},{"key":"1886_CR56","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/s41590-018-0163-6","volume":"19","author":"Q Hammer","year":"2018","unstructured":"Hammer Q, R\u00fcckert T, Romagnani C. Natural killer cell specificity for viral infections. Nat Immunol. 2018;19:800.","journal-title":"Nat Immunol"},{"key":"1886_CR57","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1056\/NEJM198906293202605","volume":"320","author":"CA Biron","year":"1989","unstructured":"Biron CA, Byron KS, Sullivan JL. Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med. 1989;320:1731\u20135.","journal-title":"N Engl J Med"},{"key":"1886_CR58","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.immuni.2007.11.012","volume":"27","author":"A Fischer","year":"2007","unstructured":"Fischer A. Human Primary Immunodeficiency Diseases. Immunity. 2007;27:835\u201345.","journal-title":"Immunity."},{"key":"1886_CR59","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/j.0105-2896.2005.00223.x","volume":"203","author":"A Fischer","year":"2005","unstructured":"Fischer A, Le Deist F, Hacein-Bey-Abina S, Andr\u00e9-Schmutz I, De Saint Basile G, De Villartay J-P, et al. Severe combined immunodeficiency. A model disease for molecular immunology and therapy. Immunol Rev. 2005;203:98\u2013109.","journal-title":"Immunol Rev"},{"key":"1886_CR60","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1084\/jem.20100603","volume":"207","author":"S Gras","year":"2010","unstructured":"Gras S, Chen Z, Miles JJ, Liu YC, Bell MJ, Sullivan LC, et al. Allelic polymorphism in the T cell receptor and its impact on immune responses. J Exp Med. 2010;207:1555\u201367.","journal-title":"J Exp Med"},{"key":"1886_CR61","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1365-2567.2008.03027.x","volume":"126","author":"A Poli","year":"2009","unstructured":"Poli A, Michel T, Th\u00e9r\u00e9sine M, Andr\u00e8s E, Hentges F, Zimmer J. CD56bright natural killer (NK) cells: an important NK cell subset. Immunology. 2009;126:458\u201365.","journal-title":"Immunology"},{"key":"1886_CR62","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1073\/pnas.0813192106","volume":"106","author":"MA Cooper","year":"2009","unstructured":"Cooper MA, Elliott JM, Keyel PA, Yang L, Carrero JA, Yokoyama WM. Cytokine-induced memory-like natural killer cells. Proc Natl Acad Sci. 2009;106:1915\u20139.","journal-title":"Proc Natl Acad Sci"},{"key":"1886_CR63","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1182\/blood-2015-06-651331","volume":"126","author":"TP Hofer","year":"2015","unstructured":"Hofer TP, Zawada AM, Frankenberger M, Skokann K, Satzl AA, Gesierich W, et al. slan-defined subsets of CD16-positive monocytes: impact of granulomatous inflammation and M-CSF receptor mutation. Blood. 2015;126:2601\u201310.","journal-title":"Blood"},{"key":"1886_CR64","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1038\/mi.2016.99","volume":"10","author":"M Swiecki","year":"2017","unstructured":"Swiecki M, Miller HL, Sesti-Costa R, Cella M, Gilfillan S, Colonna M. Microbiota induces tonic CCL2 systemic levels that control pDC trafficking in steady state. Mucosal Immunol. 2017;10:936\u201345.","journal-title":"Mucosal Immunol"},{"key":"1886_CR65","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nrmicro1657","volume":"5","author":"E Tupin","year":"2007","unstructured":"Tupin E, Kinjo Y, Kronenberg M. The unique role of natural killer T cells in the response to microorganisms. Nat Rev Microbiol. 2007;5:405\u201317.","journal-title":"Nat Rev Microbiol"},{"key":"1886_CR66","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1093\/infdis\/jir660","volume":"204","author":"T Banovic","year":"2011","unstructured":"Banovic T, Yanilla M, Simmons R, Robertson I, Schroder WA, Raffelt NC, et al. Disseminated varicella infection caused by varicella vaccine strain in a child with low invariant natural killer T cells and diminished CD1d lxpression. J Infect Dis. 2011;204:1893\u2013901.","journal-title":"J Infect Dis"},{"key":"1886_CR67","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1086\/378503","volume":"188","author":"O Levy","year":"2003","unstructured":"Levy O, Orange JS, Hibberd P, Steinberg S, LaRussa P, Weinberg A, et al. Disseminated varicella infection due to the vaccine strain of varicella-Zoster virus, in a patient with a novel deficiency in natural killer T cells. J Infect Dis. 2003;188:948\u201353.","journal-title":"J Infect Dis"},{"key":"1886_CR68","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/intimm\/dxp113","volume":"22","author":"X Zhou","year":"2010","unstructured":"Zhou X, Lv J, Bu D, Yu L, Yang Y, Zhao J, et al. Copy number variation of FCGR3A rather than FCGR3B and FCGR2B is associated with susceptibility to anti-GBM disease. Int Immunol. 2010;22:45\u201351.","journal-title":"Int Immunol"},{"key":"1886_CR69","doi-asserted-by":"publisher","first-page":"3282","DOI":"10.1093\/hmg\/ddq216","volume":"19","author":"HA Niederer","year":"2010","unstructured":"Niederer HA, Willcocks LC, Rayner TF, Yang W, Lau YL, Williams TN, et al. Copy number, linkage disequilibrium and disease association in the FCGR locus. Hum Mol Genet. 2010;19:3282\u201394.","journal-title":"Hum Mol Genet"},{"key":"1886_CR70","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/humu.22031","volume":"33","author":"JI Robinson","year":"2012","unstructured":"Robinson JI, Carr IM, Cooper DL, Rashid LH, Martin SG, Emery P, et al. Confirmation of association of FCGR3B but not FCGR3A copy number with susceptibility to autoantibody positive rheumatoid arthritis. Hum Mutat. 2012;33:741\u20139.","journal-title":"Hum Mutat"},{"key":"1886_CR71","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/gene.2015.25","volume":"16","author":"SQ Nagelkerke","year":"2015","unstructured":"Nagelkerke SQ, Tacke CE, Breunis WB, Geissler J, Sins JWR, Appelhof B, et al. Nonallelic homologous recombination of the FCGR2\/3 locus results in copy number variation and novel chimeric FCGR2 genes with aberrant functional expression. Genes Immun. 2015;16:422\u20139.","journal-title":"Genes Immun"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-025-01886-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-025-01886-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-025-01886-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T17:02:05Z","timestamp":1777309325000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-025-01886-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,24]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1886"],"URL":"https:\/\/doi.org\/10.1007\/s10875-025-01886-y","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,24]]},"assertion":[{"value":"25 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"98"}}